{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:21:28Z","timestamp":1781497288430,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002980","name":"Dalian University of Technology","doi-asserted-by":"publisher","award":["2024-ZLKF-33"],"award-info":[{"award-number":["2024-ZLKF-33"]}],"id":[{"id":"10.13039\/501100002980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Liaoning Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023-MSBA-018"],"award-info":[{"award-number":["2023-MSBA-018"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["DUT23YG228"],"award-info":[{"award-number":["DUT23YG228"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["DUT24MS018"],"award-info":[{"award-number":["DUT24MS018"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jpba.2025.117083","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T06:47:19Z","timestamp":1753426039000},"page":"117083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Unraveling the plasma dynamics, oxidative metabolism and excretion behavior of M-PEG6-OH by UPLC-MS\/MS"],"prefix":"10.1016","volume":"266","author":[{"given":"Yingxia","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runran","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meichen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixian","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2025.117083_bib1","doi-asserted-by":"crossref","first-page":"2494775","DOI":"10.1080\/10717544.2025.2494775","article-title":"PEGylation technology: addressing concerns, moving forward","volume":"32","author":"Simberg","year":"2025","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jpba.2025.117083_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.882363","article-title":"Understanding the role and impact of poly (Ethylene Glycol) (PEG) on nanoparticle formulation: implications for COVID-19 vaccines","volume":"10","author":"Pad\u00edn-Gonz\u00e1lez","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jpba.2025.117083_bib3","doi-asserted-by":"crossref","first-page":"2001616","DOI":"10.1002\/advs.202001616","article-title":"A cell-free platform based on nisin biosynthesis for discovering novel lanthipeptides and guiding their overproduction in vivo","volume":"7","author":"Liu","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jpba.2025.117083_bib4","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1002\/jssc.201901340","article-title":"Recent advances in the bioanalytical methods of polyethylene glycols and PEGylated pharmaceuticals","volume":"43","author":"Zhang","year":"2020","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2025.117083_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0305-7372(02)80004-4","article-title":"Pegylation: engineering improved pharmaceuticals for enhanced therapy","volume":"28","author":"Molineux","year":"2002","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jpba.2025.117083_bib6","doi-asserted-by":"crossref","first-page":"2010284","DOI":"10.1002\/adfm.202010284","article-title":"Biodegradable hydrophobic injectable polymers for drug delivery and regenerative medicine","volume":"31","author":"Arun","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jpba.2025.117083_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2022.09.031","article-title":"Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products","volume":"351","author":"Ibrahim","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpba.2025.117083_bib8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jconrel.2021.01.013","article-title":"PEGylation enables subcutaneously administered nanoparticles to induce antigen-specific immune tolerance","volume":"331","author":"Li","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpba.2025.117083_bib9","doi-asserted-by":"crossref","first-page":"9814","DOI":"10.1038\/s41467-024-54076-6","article-title":"Exactly defined molecular weight poly(ethylene glycol) allows for facile identification of PEGylation sites on proteins","volume":"15","author":"Burggraef","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpba.2025.117083_bib10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jconrel.2023.01.021","article-title":"Accelerated clearance by antibodies against methoxy PEG depends on pegylation architecture","volume":"354","author":"Lin","year":"2023","journal-title":"J. Control. Release."},{"key":"10.1016\/j.jpba.2025.117083_bib11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1021\/bc200551b","article-title":"Role of the methoxy group in immune responses to mPEG-protein conjugates","volume":"23","author":"Sherman","year":"2012","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.jpba.2025.117083_bib12","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/17425247.2016.1182485","article-title":"Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications","volume":"13","author":"D'Souza","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jpba.2025.117083_bib13","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1002\/jps.21245","article-title":"Nano-sized assemblies of a PEG-docetaxel conjugate as a formulation strategy for docetaxel","volume":"97","author":"Liu","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2025.117083_bib14","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3390\/nano11061446","article-title":"Biological potential of polyethylene glycol (PEG)-functionalized graphene quantum dots in in vitro neural stem\/progenitor cells","volume":"11","author":"Ji","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jpba.2025.117083_bib15","series-title":"Polymer-Protein Conjugates","first-page":"61","article-title":"4 - PEG\u2013protein conjugates: nonclinical and clinical toxicity considerations","author":"Turecek","year":"2020"},{"key":"10.1016\/j.jpba.2025.117083_bib16","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s40259-024-00684-z","article-title":"Adverse impacts of PEGylated protein therapeutics: a targeted literature review","volume":"38","author":"Lee","year":"2024","journal-title":"BioDrugs"},{"key":"10.1016\/j.jpba.2025.117083_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1248\/bpb.b13-00661","article-title":"Discussion about several potential drawbacks of PEGylated therapeutic proteins","volume":"37","author":"Zhang","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jpba.2025.117083_bib18","article-title":"Hypersensitivity to polyethylene glycol in adults and children: an emerging challenge","volume":"92","author":"Bianchi","year":"2021","journal-title":"Acta Biomed."},{"key":"10.1016\/j.jpba.2025.117083_bib19","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1080\/14686996.2019.1627174","article-title":"PEGylated liposomes: immunological responses","volume":"20","author":"Mohamed","year":"2019","journal-title":"Sci. Technol. Adv. Mater."},{"key":"10.1016\/j.jpba.2025.117083_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102163","article-title":"Anti-PEG antibodies: current situation and countermeasures","volume":"55","author":"Fu","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.jpba.2025.117083_bib21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154-155","author":"Kozma","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jpba.2025.117083_bib22","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1021\/acsnano.2c12193","article-title":"Antibodies against Poly(ethylene glycol) activate innate immune cells and induce hypersensitivity reactions to PEGylated nanomedicines","volume":"17","author":"Chen","year":"2023","journal-title":"ACS Nano."},{"key":"10.1016\/j.jpba.2025.117083_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1248\/bpb.b13-00661","article-title":"Discussion about several potential drawbacks of PEGylated therapeutic proteins","volume":"37","author":"Zhang","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jpba.2025.117083_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425255.2014.967679","article-title":"Effects of pharmaceutical PEGylation on drug metabolism and its clinical concerns","volume":"10","author":"Zhang","year":"2014","journal-title":"Expert Opin. Drug. Met."},{"key":"10.1016\/j.jpba.2025.117083_bib25","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.drudis.2014.06.002","article-title":"Pharmacokinetics, metabolism and distribution of PEGs and PEGylated proteins: quo vadis?","volume":"19","author":"Baumann","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jpba.2025.117083_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2018.06.002","article-title":"A minimal physiologically based pharmacokinetic model that predicts anti-PEG IgG-mediated clearance of PEGylated drugs in human and mouse","volume":"284","author":"McSweeney","year":"2018","journal-title":"J. Control. Release."},{"key":"10.1016\/j.jpba.2025.117083_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106304","article-title":"Population pharmacokinetic\/pharmacodynamic analysis of PEG-rhGH enhances confidence in exploring dosing schemes with longer intervals","volume":"179","author":"Cheng","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2025.117083_bib28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.actbio.2016.05.019","article-title":"Control of silk microsphere formation using polyethylene glycol (PEG)","volume":"39","author":"Wu","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jpba.2025.117083_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/mutage\/17.3.261","article-title":"Low molecular weight polyethylene glycol induces chromosome aberrations in Chinese hamster cells cultured in vitro","volume":"17","author":"Biondi","year":"2002","journal-title":"Mutagenesis"},{"key":"10.1016\/j.jpba.2025.117083_bib30","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/jps.2600830432","article-title":"Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice","volume":"83","author":"Yamaoka","year":"1994","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2025.117083_bib31","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jpba.2018.12.030","article-title":"Bioanalytical method validation: new FDA guidance vs. EMA guideline. Better or worse?","volume":"165","author":"Kaza","year":"2019","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525004248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525004248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:59:59Z","timestamp":1772780399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525004248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":31,"alternative-id":["S0731708525004248"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117083","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling the plasma dynamics, oxidative metabolism and excretion behavior of M-PEG6-OH by UPLC-MS\/MS","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117083"}}